Milestone For Bristol Firm Developing Innovative Breast Cancer Detection Product
Micrima, the Bristol company developing a safe, low-cost way of improving breast cancer detection, has gained CE marking for its MARIA (Multistatic Array processing for Radiowave Image Acquisition) product, paving the way for further supportive clinical trials in the UK and expansion into Europe.
This European regulatory approval is a significant milestone for the company, originally a spin-out from the University of Bristol, enabling it to stage further supportive clinical trials in preparation for heading its ground-breaking system towards the European market. The non-invasive technology is on track to provide the first true alternative to X-ray mammography for decades.
Micrima executive chairman Roy Johnson said: “Gaining our CE marking is hugely important, proving, as it does, that the firm’s innovative MARIA system complies with all the necessary EU safety, health and environmental requirements.
Read the full article on bristol-business.net here.